Fc-mediated anomalous biodistribution of therapeutic antibodies in immunodeficient mouse models.

[No authors listed]

GSID: fd337QJ6SqwJ

Abstract

A critical benchmark in the development of antibody-based therapeutics is demonstration of efficacy in preclinical mouse models of human disease, many of which rely on …